AU6212398A - 2-amino-substituted pyridines which can be used for the treatment of arteriosclerosis and hyperclipoproteinaemia - Google Patents
2-amino-substituted pyridines which can be used for the treatment of arteriosclerosis and hyperclipoproteinaemiaInfo
- Publication number
- AU6212398A AU6212398A AU62123/98A AU6212398A AU6212398A AU 6212398 A AU6212398 A AU 6212398A AU 62123/98 A AU62123/98 A AU 62123/98A AU 6212398 A AU6212398 A AU 6212398A AU 6212398 A AU6212398 A AU 6212398A
- Authority
- AU
- Australia
- Prior art keywords
- hyperclipoproteinaemia
- arteriosclerosis
- amino
- treatment
- substituted pyridines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19704243 | 1997-02-05 | ||
| DE19704243A DE19704243A1 (en) | 1997-02-05 | 1997-02-05 | New 2-amino-substituted pyridines |
| PCT/EP1998/000362 WO1998034920A1 (en) | 1997-02-05 | 1998-01-23 | 2-amino substituted pyridines for use in the treatment of arteriosclerosis and hyperlipoproteinaemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU6212398A true AU6212398A (en) | 1998-08-26 |
| AU730109B2 AU730109B2 (en) | 2001-02-22 |
Family
ID=7819326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU62123/98A Ceased AU730109B2 (en) | 1997-02-05 | 1998-01-23 | 2-amino-substituted pyridines which can be used for the treatment of arteriosclerosis and hyperclipoproteinaemia |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0973744A1 (en) |
| JP (1) | JP2001510478A (en) |
| KR (1) | KR20000070756A (en) |
| CN (1) | CN1252057A (en) |
| AU (1) | AU730109B2 (en) |
| BG (1) | BG103631A (en) |
| BR (1) | BR9807181A (en) |
| CA (1) | CA2279636A1 (en) |
| CZ (1) | CZ279299A3 (en) |
| DE (1) | DE19704243A1 (en) |
| HU (1) | HUP0001022A2 (en) |
| ID (1) | ID24208A (en) |
| IL (1) | IL131127A0 (en) |
| NO (1) | NO993738L (en) |
| NZ (1) | NZ337011A (en) |
| PL (1) | PL334899A1 (en) |
| SK (1) | SK104099A3 (en) |
| TR (1) | TR199901857T2 (en) |
| WO (1) | WO1998034920A1 (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| OA12625A (en) | 2001-06-22 | 2006-06-12 | Pfizer Prod Inc | Pharmaceutical compositions of adsorbates of amorphous drug. |
| ES2333645T3 (en) | 2001-06-22 | 2010-02-25 | Bend Research, Inc. | PHARMACEUTICAL COMPOSITIONS OF DISPERSIONS OF MEDICINES AND NEUTRAL POLYMERS. |
| EP1469832B2 (en) | 2002-02-01 | 2016-10-26 | Bend Research, Inc. | Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials |
| BRPI0408442A (en) | 2003-03-17 | 2006-04-04 | Japan Tobacco Inc | method for increasing the oral bioavailability of s- [2 - ([[1- (2-ethylbutyl) cyclohexyl] carbonyl] amino) phenyl] 2-methylpropanothioate |
| CA2532931A1 (en) | 2003-08-04 | 2005-02-10 | Pfizer Products Inc. | Pharmaceutical compositions of adsorbates of amorphous drugs and lipophilic microphase-forming materials |
| CL2004001884A1 (en) | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | DRYING PROCEDURE FOR SPRAYING FOR THE FORMATION OF SOLID DISPERSIONS AMORPHES OF A PHARMACO AND POLYMERS. |
| EP1670446A2 (en) | 2003-09-26 | 2006-06-21 | Japan Tobacco Inc. | Method of inhibiting remnant lipoprotein production |
| DOP2005000123A (en) * | 2004-07-02 | 2011-07-15 | Merck Sharp & Dohme | CETP INHIBITORS |
| WO2006032987A1 (en) * | 2004-09-23 | 2006-03-30 | Pfizer Products Inc. | Indoline compounds and their use in the treatment of arteriosclerosis |
| WO2006082518A1 (en) | 2005-02-03 | 2006-08-10 | Pfizer Products Inc. | Pharmaceutical compositions with enhanced performance |
| US20100113473A1 (en) | 2008-10-30 | 2010-05-06 | Player Mark R | Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5169857A (en) * | 1988-01-20 | 1992-12-08 | Bayer Aktiengesellschaft | 7-(polysubstituted pyridyl)-hept-6-endates useful for treating hyperproteinaemia, lipoproteinaemia or arteriosclerosis |
-
1997
- 1997-02-05 DE DE19704243A patent/DE19704243A1/en not_active Withdrawn
-
1998
- 1998-01-23 JP JP53369198A patent/JP2001510478A/en active Pending
- 1998-01-23 BR BR9807181-5A patent/BR9807181A/en not_active IP Right Cessation
- 1998-01-23 PL PL98334899A patent/PL334899A1/en unknown
- 1998-01-23 CA CA002279636A patent/CA2279636A1/en not_active Abandoned
- 1998-01-23 SK SK1040-99A patent/SK104099A3/en unknown
- 1998-01-23 HU HU0001022A patent/HUP0001022A2/en unknown
- 1998-01-23 EP EP98904126A patent/EP0973744A1/en not_active Ceased
- 1998-01-23 NZ NZ337011A patent/NZ337011A/en unknown
- 1998-01-23 CZ CZ992792A patent/CZ279299A3/en unknown
- 1998-01-23 TR TR1999/01857T patent/TR199901857T2/en unknown
- 1998-01-23 IL IL13112798A patent/IL131127A0/en unknown
- 1998-01-23 AU AU62123/98A patent/AU730109B2/en not_active Ceased
- 1998-01-23 ID IDW990821D patent/ID24208A/en unknown
- 1998-01-23 KR KR1019997007015A patent/KR20000070756A/en not_active Application Discontinuation
- 1998-01-23 CN CN98803916A patent/CN1252057A/en active Pending
- 1998-01-23 WO PCT/EP1998/000362 patent/WO1998034920A1/en not_active Application Discontinuation
-
1999
- 1999-08-02 NO NO993738A patent/NO993738L/en not_active Application Discontinuation
- 1999-08-03 BG BG103631A patent/BG103631A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR9807181A (en) | 2000-01-25 |
| NZ337011A (en) | 2001-04-27 |
| CA2279636A1 (en) | 1998-08-13 |
| NO993738D0 (en) | 1999-08-02 |
| CZ279299A3 (en) | 1999-11-17 |
| IL131127A0 (en) | 2001-01-28 |
| BG103631A (en) | 2000-11-30 |
| TR199901857T2 (en) | 1999-10-21 |
| AU730109B2 (en) | 2001-02-22 |
| HUP0001022A2 (en) | 2000-09-28 |
| DE19704243A1 (en) | 1998-08-06 |
| KR20000070756A (en) | 2000-11-25 |
| NO993738L (en) | 1999-09-17 |
| ID24208A (en) | 2000-07-13 |
| WO1998034920A1 (en) | 1998-08-13 |
| PL334899A1 (en) | 2000-03-27 |
| JP2001510478A (en) | 2001-07-31 |
| SK104099A3 (en) | 2000-01-18 |
| EP0973744A1 (en) | 2000-01-26 |
| CN1252057A (en) | 2000-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL130181A0 (en) | Substituted pyrimidone and pyridone compounds and methods of use | |
| AU3607095A (en) | Use of substituted pyridines as pest-control agents and fungicides | |
| AU7264298A (en) | Apparatus and method for the reduction of snoring | |
| AU4171500A (en) | Flupirtine in the treatment of fibromyalgia and related conditions | |
| AU4520801A (en) | Novel substituted phenanthridinones and methods of use thereof | |
| AU1751795A (en) | Liposome compositions and methods for the treatment of atherosclerosis | |
| HU9802721D0 (en) | Method and composition for the treatment and prevention of hyperuricemia | |
| AU4009795A (en) | Heterocyclic compounds and their use | |
| IL136110A0 (en) | Methods and compositions for the treatment of psoriasis | |
| AU9016898A (en) | Methods and compositions for treatment of restenosis | |
| EP1239855A4 (en) | Method for the prevention and/or treatment of atherosclerosis | |
| AU6212398A (en) | 2-amino-substituted pyridines which can be used for the treatment of arteriosclerosis and hyperclipoproteinaemia | |
| AU1556497A (en) | Agents for the treatment and prevention of aids | |
| AU2387097A (en) | Substituted benzylamines and their use for the treatment of depression | |
| AU2821295A (en) | Compositions and methods for the treatment of tumors | |
| AU5923998A (en) | 2-benzoylamino-3-phenylpropenamide derivatives and methods of using the same | |
| AU2139097A (en) | Methods of treating or preventing sleep apnea | |
| AU6646798A (en) | Method and apparatus for the destruction of articles | |
| AU4505996A (en) | 7-vinylidene cephalosporins and methods of using the same | |
| AU8809098A (en) | Procedure and apparatus for the treatment of waste | |
| AU1459500A (en) | Dihydropyridine compounds and methods of use | |
| AU1489999A (en) | Apparatus and procedure for the coating of objects | |
| HK1021314A1 (en) | Formulation for the treatment and/or prophylaxis of dementia | |
| AU8049098A (en) | Composition and methods for the treatment of inflammatory diseases | |
| AU3735900A (en) | Methods of treatment and prevention of restenosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |